Since most cases of dementia are caused by a complex mixture of factors, the NHS only offers genetic testing in rare, specific circumstances. Genetic tests can be used to tell whether someone has ...

Genetic testing firms focus on DTC services and aiding disease detection and treatment efficacy. High growth potential in genetic testing market, segmented into screening, treatment, and monitoring.

It is a collaboration between the PharmGKB group and PGRN. It develops guidelines to help clinicians use genetic test results in optimization drug therapy. The guidelines are peer reviewed and ...

In just 24 hours, this platform can sequence 600 giga-bases when using ... then you will need to do gene testing for the parents and siblings.” With traditional sequencing, that can take a ...

Of the final sample, 31% of patients received at least one genetic test overall, but only 11% received concordant testing and at least one other test. The current study explored the role of ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects. The study is published in the QJM ...

The therapy is being developed for HER2-mutant advanced NSCLC. Credit: Jo Panuwat D/Shutterstock. The US Food and Drug Administration (FDA) has granted priority review to Boehringer Ingelheim’s new ...

The genetics behind Alzheimer's disease and other forms of dementia is complex, and DNA testing kits like 23andme cannot tell the complete story about a person's risk of developing the condition.

can cause syndromic forms of HI although they are not typically screened for during routine genetic testing for this condition. We aimed to assess the prevalence of disease-causing contiguous gene ...